1. Inflammatory cytokines enhance procoagulant activity of platelets and endothelial cells through phosphatidylserine exposure in patients with essential hypertension
- Author
-
Xiaohui Zhang, Bin Song, Ying Wang, Yang Xu, Dongxia Tong, Jihe Li, Yue Liu, Xinhua Yin, Fuyang Chen, Wenxiu Liu, Yang Li, and Na Liu
- Subjects
Blood Platelets ,medicine.medical_specialty ,Phosphatidylserines ,030204 cardiovascular system & hematology ,Pharmacology ,Fibrin ,Proinflammatory cytokine ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Thrombin ,Cell-Derived Microparticles ,Internal medicine ,medicine ,Humans ,Platelet ,030212 general & internal medicine ,Blood Coagulation ,Hematology ,biology ,business.industry ,Endothelial Cells ,Phosphatidylserine ,Clotting time ,Coagulation ,chemistry ,biology.protein ,Cytokines ,Essential Hypertension ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
The exact mechanism of the prothrombotic state of essential hypertension (EH) patients remains elusive. Our objective was to assess whether phosphatidylserine (PS) exposure on endothelial cells (ECs), platelets, and microparticles (MPs) can account for the hypercoagulability in EH patients. PS exposure on cells and MPs, mainly from platelets and ECs was analyzed with flow cytometry. Procoagulant activity (PCA) was evaluated by purified coagulation complex assays, clotting time, and fibrin turbidity. We found that EH patients exhibited elevated levels of PS+ platelets, serum-cultured ECs, MPs, endothelial-derived MPs and platelet-derived MPs compared to the controls (all P
- Published
- 2020
- Full Text
- View/download PDF